欢迎您访问《中华养生保健》官方网站!

中华养生保健 ›› 2024, Vol. 42 ›› Issue (19): 4-8.

• 论著 • 上一篇    下一篇

IRF9、PSMA5联合外周血巨噬细胞M1/M2极化状态预测类风湿性关节炎进展的多元回归模型

关岳1, 李新1, 杨贺旻2, 徐思宇3, 史丽东1, 刘扬洋1, 孔令丹1, 秦影1,*   

  1. 1.黑龙江省齐齐哈尔医学院附属第三医院风湿免疫科,黑龙江 齐齐哈尔,161006;
    2.黑龙江省齐齐哈尔医学院附属第三医院中心实验室,黑龙江 齐齐哈尔,161006;
    3.黑龙江省齐齐哈尔医学院附属第三医院检验中心,黑龙江 齐齐哈尔,161006
  • 出版日期:2024-10-01 发布日期:2024-09-25
  • 通讯作者: *秦影,E-mail:Qy15603629068@qmu.edu.cn。
  • 作者简介:关岳(1987—),女,满族,籍贯:黑龙江省绥化市,硕士研究生,主治医师,研究方向:风湿免疫。
  • 基金资助:
    2023年黑龙江省省属本科高校基本科研业务费项目(2023-KYYWF-0878)

Multiple Regression Model of IRF9, PSMA5 Combined with M1/M2 Polarization Status of Peripheral Blood Macrophages to Predict Rheumatoid Arthritis Progression

GUAN Yue1, LI Xin1, YANG He-min2, XU Si-yu3, SHI Li-dong1, LIU Yang-yang1, KONG Ling-dan1, QIN Ying1,*   

  1. 1. Department of rheumatology and immunology, the Third Affiliated Hospital of Qiqihar Medical University, Qiqihar Heilongjiang, 161006, China;
    2. Central Laboratory, the Third Affiliated Hospital of Qiqihar Medical University, Qiqihar Heilongjiang, 161006, China;
    3. Inspection Center, the Third Affiliated Hospital of Qiqihar Medical University, Qiqihar Heilongjiang, 161006, China
  • Online:2024-10-01 Published:2024-09-25

摘要: 目的 探究干扰素调节因子9(IRF9)、蛋白酶体a5亚基(PSMA5)联合外周血巨噬细胞经典激活(M1)和替代激活(M2)极化状态对类风湿性关节炎(RA)进展的预测价值。方法 选取2022年2月—2023年2月齐齐哈尔医学院附属第三医院收治的87例RA患者,根据疾病严重程度将其分为活动期组和缓解期组。比较两组患者IRF9、PSMA5、M1/M2比值,采用二元Logistic回归分析其与RA进展的关系,构建风险预测模型,利用ROC曲线、校准曲线与决策曲线评价其预测价值。结果 缓解期组共49例患者(56.32%),活动期组共38例患者(43.68%),两组在累及关节数、关节压痛指数及关节肿胀指数等方面,差异有统计学意义(P<0.05);活动期患者IRF9、PSMA5、M1、M1/M2比例显著高于缓解期组,但M2显著低于缓解期组,差异有统计学意义(P<0.05); Logistic回归分析显示IRF9、PSMA5、M1/M2比值是RA疾病进展的危险因素;ROC分析用于预测RA进展,AUC值显示M1/M2为0.690,IRF9为0.664,PSMA5为0.733。结论 M1/M2、IRF9、PSMA5与RA疾病进展相关,有助于评估RA疾病进展。

关键词: 类风湿关节炎, 巨噬细胞, 干扰素调节因子9, 蛋白酶体a5亚基

Abstract: Objective To study the predictive value of IRF9 and PSMA5 combined with M1 and M2 macrophage polarization on rheumatoid arthritis (RA) progression. Methods A total of 87 RA patients were divided into active and remission groups based on disease severity. IRF9 and PSMA5 expression, M1 and M2 macrophage proportions, and the M1/M2 ratio were compared. Logistic regression and ROC analysis were used to assess predictive performance. Results Higher expression of IRF9 and PSMA5 was seen in active RA patients. M1/M2 ratio was higher in active RA. Logistic regression identified IRF9, PSMA5, and M1/M2 ratio as RA progression risk factors. AUC values for predicting RA progression were 0.690 for M1/M2, 0.664 for IRF9, and 0.733 for PSMA5. Conclusion M1/M2 polarization, IRF9, and PSMA5 levels were elevated in RA patients and correlated with disease progression. These markers could be valuable for assessing and evaluating RA progression clinically.

Key words: rheumatoid arthritis, macrophage, interferon regulatory factor 9, proteasome a5 subunit

中图分类号: